Skip to main content
Zealand Pharma A/S (CPH: ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
886.50
+15.00 (1.72%)
Aug 30, 2024, 4:59 PM CET

Zealand Pharma Revenue

Zealand Pharma had revenue of 34.13M DKK in the quarter ending June 30, 2024, with 227.96% growth. This brings the company's revenue in the last twelve months to 367.97M, up 301.39% year-over-year. In the year 2023, Zealand Pharma had annual revenue of 342.79M with 229.65% growth.

Revenue (ttm)
367.97M
Revenue Growth
+301.39%
P/S Ratio
145.15
Revenue / Employee
1.28M
Employees
253
Market Cap
62.88B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023342.79M238.80M229.65%
Dec 31, 2022103.99M-4.56M-4.20%
Dec 31, 2021108.55M-83.46M-43.47%
Dec 31, 2020192.00M150.67M364.52%
Dec 31, 201941.33M3.36M8.84%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk A/S 258.00B
Coloplast A/S 26.30B
Genmab A/S 19.02B
Demant A/S 22.84B
H. Lundbeck A/S 20.67B
H. Lundbeck A/S 20.67B
ALK-Abelló A/S 5.18B
Ambu A/S 5.08B
Revenue Rankings

Zealand Pharma News

More News